CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
NASDAQ · Healthcare · Medical - Healthcare Plans · US
$4.44
−0.89%Year over year
Reported trailing growth
- Revenue
- +54.0%
- EBITDA
- +59.4%
- EBIT
- +56.4%
- EPS
- +53.4%
- Free cash flow
- +254.0%
- Operating cash flow
- +264.8%
Forward estimates
Based on analyst estimates
- Revenue
- +37.7%
- EBITDA
- +465.0%
- EPS
- +282.0%
Three-year CAGR
- Revenue
- +20.6%
- EBITDA
- -86.6%
- EBIT
- -87.0%
- Net income
- -98.9%
- EPS
- -93.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026